The emerging therapy of this peptide represents a significant development in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide586248.blognody.com/51992765/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment